FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 303:782-787 October 2, 1980 Number 14 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

A scleroderma-like illness developed in a patient treated with L-5 hydroxytryptophan (L-5HTP) and carbidopa for intention myoclonus. The patient had high plasma kynurenine levels that remained high when the L-5HTP-carbidopa combination was discontinued, However, levels rose futher on drug rechallenge, suggesting that the drug unmasked an abnormality in one of the enzymes that catabolize kynurenine. Plasma kynurenine was also determined to be high in seven of 15 patients wth idiopathic scleroderma, but not in eight patients with intention myoclonus treated with L-5HTP and a decarboxylase inhibitor and in whom scleroderma did not develop or in 10 patients with Parkinson's disease treated wth L-dopa and carbidopa. Our data and studies in the literature suggest that two factors may be important in the pathogenesis of some scleroderma-like illness: high plasma serotonin and the abnormality associated with elevated kynurenine.

This article has been cited by other articles:

• MORA, G. F. (2009). Systemic Sclerosis: Environmental Factors. The Journal of Rheumatology 36: 2383-2396 [Abstract] [Full Text]  
• Lou, J.-S., Goldfarb, L., McShane, L., Gatev, P., Hallett, M. (1995). Use of Buspirone for Treatment of Cerebellar Ataxia: An Open-Label Study. Arch Neurol 52: 982-988 [Abstract]  
• Pranzatelli, M. R. (1994). Serotonin and Human Myoclonus: Rationale for the Use of Serotonin Receptor Agonists and Antagonists. Arch Neurol 51: 605-617 [Abstract]  
• Culpepper, R. C., Williams, R. G., Mease, P. J., Koepsell, T. D., Kobayashi, J. M. (1991). Natural History of the Eosinophilia-Myalgia Syndrome. ANN INTERN MED 115: 437-442 [Abstract]  
• Blauvelt, A., Falanga, V. (1991). Idiopathic and L-Tryptophan-Associated Eosinophilic Fasciitis Before and After L-Tryptophan Contamination. Arch Dermatol 127: 1159-1166 [Abstract]  
• Silver, R. M. (1991). Unraveling the Eosinophilia-Myalgia Syndrome. Arch Dermatol 127: 1214-1216 [Abstract]  
• James, T. N., Kamb, M. L., Sandberg, G. A., Silver, R. M., Kilbourne, E. M. (1991). Postmortem Studies of the Heart in Three Fatal Cases of the Eosinophilia-Myalgia Syndrome. ANN INTERN MED 115: 102-110 [Abstract]  
• Lindgren, C.E., Walker, L. A., Bolton, P. (1991). L-tryptophan Induced Eosinophilia-Myalgia Syndrome. The Journal of the Royal Society for the Promotion of Health 111: 29-30  
• Gordon, M. L., Lebwohl, M. G., Phelps, R. G., Cohen, S. R., Fleischmajer, R. (1991). Eosinophilic Fasciitis Associated With Tryptophan Ingestion: A Manifestation of Eosinophilia-Myalgia Syndrome. Arch Dermatol 127: 217-220 [Abstract]  
• Strongwater, S. L., Woda, B. A., Yood, R. A., Rybak, M. E., Sargent, J., DeGirolami, U., Smith, T. W., Varnis, C., Allen, S., Murphy, K., Malhotra, R., Romain, P. L. (1990). Eosinophilia-Myalgia Syndrome Associated With L-Tryptophan Ingestion: Analysis of Four Patients and Implications for Differential Diagnosis and Pathogenesis. Arch Intern Med 150: 2178-2186 [Abstract]  
• Martin, R. W., Duffy, J., Engel, A. G., Lie, J. T., Bowles, C. A., Moyer, T. P., Gleich, G. J. (1990). The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion: Clinical Features in 20 Patients and Aspects of Pathophysiology. ANN INTERN MED 113: 124-134 [Abstract]  
• Slutsker, L., Hoesly, F. C., Miller, L., Williams, L. P., Watson, J. C., Fleming, D. W. (1990). Eosinophilia-Myalgia Syndrome Associated With Exposure to Tryptophan From a Single Manufacturer. JAMA 264: 213-217 [Abstract]  
• Freundlich, B., Werth, V. P., Rook, A. H., O'Connor, C. R., Schumacher, H. R., Leyden, J. J., Stolley, P. D. (1990). L-Tryptophan Ingestion Associated with Eosinophilic Fasciitis but Not Progressive Systemic Sclerosis. ANN INTERN MED 112: 758-762 [Abstract]  
• Clauw, D. J., Nashel, D. J., Umhau, A., Katz, P. (1990). Tryptophan-Associated Eosinophilic Connective-Tissue Disease: A New Clinical Entity?. JAMA 263: 1502-1506 [Abstract]  
• Varga, J., Peltonen, J., Uitto, J., Jimenez, S. (1990). Development of Diffuse Fasciitis with Eosinophilia during L-Tryptophan Treatment: Demonstration of Elevated Type I Collagen Gene Expression in Affected Tissues: A Clinicopathologic Study of Four Patients. ANN INTERN MED 112: 344-351 [Abstract]